United Kingdom researchers 'optimistic' antidote will be ready soon

Despite that, he also warned against pinning all hopes on a vaccine, because a successful one may never be found.

Plans have been revealed for the United Kingdom to have 30 million coronavirus vaccines given to the public by September, according to Business Secretary Alok Sharma.

Business Secretary Alok Sharma said the additional funding would support teams at Oxford University and Imperial College London engaged in the global race to find a vaccine that could finally end the devastating pandemic.

We ask a virologist how likely this timeline is and what it might mean for the United States if they succeed.

Yes, work on a coronavirus vaccine started fast and has continued at a breakneck pace at labs all over the world, but it's not a simple process.

At the moment, we should be as realistic as possible and assume that a vaccine won't be available until early 2021 at the absolute earliest.

A vaccine is critical to returning to work, global trade and tourism, "so if we have vaccine nationalism, and one country looks after itself first, and at the expense of the rest of the world, everyone is going to continue to suffer", Halton said.

"The UK will be first to get access but we can also ensure that in addition to supporting people here in the UK we're able to make the vaccine available to developing countries at the lowest possible cost", he told the daily No 10 press briefing.

The maker of Lucky Strike cigarette said once it gets approval from the U.S. Food and Drug administration (FDA) for the vaccine, it would progress to Phase 1 trials or testing on humans.

There would be enormous moral pressure on all adults to have a vaccine against COVID-19 when one became available, she warned.

"The speed at which Oxford University has designed and organised these complex trials is genuinely unprecedented", he said.

Australia has a local vaccine manufacturing plant in CSL but it may not be able to produce all the different types of vaccine under development.

The vaccine, known as ChAdOx1 nCoV-19, is being developed by the Jenner Institute and Oxford Vaccine Group at the University of Oxford.

She said a "it's all good" attitude would reduce social distancing and could cause a "really bad outcome" for the elderly and immunocompromised.

That is why the government is also working with other companies. However, these plans are still contingent upon the successful development of vaccines later this year. Professor Peter Openshaw, who is part of the Imperial College London trials, spoke to Sky News about the likelihood of their vaccine being ready by September.

Related news

[an error occurred while processing the directive]